Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A **dehydrogenase enzyme** is a member of the oxidoreductase family (EC class 1), catalyzing the removal of hydrogen atoms from substrates in oxidation-reduction reactions[1][3][6][8]. Typically, dehydrogenases use coenzymes such as NAD+, NADP+, FAD, or FMN as electron acceptors, facilitating essential steps in major metabolic pathways including glycolysis, the citric acid cycle, fatty acid oxidation, and amino acid catabolism[1][3][4][8]. The term "dehydrogenase enzyme" is generic and refers to a large group of distinct enzymes (such as alcohol dehydrogenase, lactate dehydrogenase, pyruvate dehydrogenase, aldehyde dehydrogenase, etc.), each with specific substrates and biological roles[3][7][1]. Dysregulation or mutation of individual dehydrogenases is associated with diseases including certain cancers, metabolic disorders, cardiovascular and neurological diseases[1][2]. Certain dehydrogenases can serve as biomarkers (e.g., elevated serum LDH as a marker of tissue damage or tumor activity, ALDH activity for some cancer stem cells)[1][2]. Many drugs act by targeting specific dehydrogenases (e.g., disulfiram inhibits aldehyde dehydrogenase for alcohol aversion therapy; metformin inhibits mitochondrial glycerol-3-phosphate dehydrogenase for diabetes management; brequinar targets dihydroorotate dehydrogenase in cancer)[1][8]. Because "dehydrogenase enzyme" is a non-specific, collective term rather than a single defined molecular target, information may need to be refined to a specific isoform or family member for actionable therapeutic or research use[3].
Enzyme inhibition, Enzyme activation, Modulation of metabolic flux
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dehydrogenase enzyme.